Skip to main content

Table 2 Procedural characteristics of TAVR patients

From: Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement

  Non-diabetic (N = 285) Diabetic (N = 158) P-value
NIDDM (N = 114) IDDM (N = 44)
Approach
 Trans-femoral 209 (76) 86 (79) 31 (74) 0.53
 Trans-apical 49 (18) 19 (17) 9 (21)
 Other 17 (6) 3 (3) 2 (5)
Anesthesia
 General 89 (39) 34 (34) 12 (36) 0.55
 Conscious sedation 140 (61) 66 (66) 21 (61)
Valve type
 SAPIEN XT 109 (41) 48 (45) 18 (45) 0.35
 CoreValve 159 (58) 55 (51) 20 (50)
 Other 5 (1) 2 (2) 0 (0)
Valve size
 23 mm 52 (20) 19 (18) 9 (24) 0.77
 25 mm 0 (0) 1 (1) 0 (0)
 26 mm 106 (41) 45 (44) 13 (35)
 29 mm 93 (36) 34 (33) 13 (35)
 31 mm 6 (2) 4 (4) 2 (5)
 Valve-in-valve 25 (9) 12 (11) 8 (20) 0.11
 Procedural success 262 (98) 103 (97) 38 (100) 0.59
 Pre procedural EF 55 ± 12 56 ± 12 54 ± 12 0.48
 Pre-procedural moderate to severe MR 74 (26) 26 (23) 10 (23) 0.76
 Post-procedural moderate to severe AR 37 (13) 14 (12) 2 (5) 0.27
  1. All values expressed as N (%)
  2. NIDDM non-insulin dependent diabetes mellitus, IDDM insulin dependent diabetes mellitus